Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aventis U.S. Team Has RPR Execs Heading Commercial Op & Finance

Executive Summary

Rhone-Poulenc Rorer Senior VP and General Manager John Leone is heading Aventis' North American Pharmaceuticals commercial operations - sales and marketing.

You may also be interested in...



Sanofi U.S. strategy exec

Sanofi-Aventis names Juergen Lasowski, PhD, to head U.S. business development & strategy. He formerly served as Aventis VP-strategic planning & business and head of strategic development at predecessor company Hoechst Marion Roussel. Lasowski will report to Tim Rothwell, who became Sanofi-Aventis U.S. president following the completion of the merger (1"The Pink Sheet" June 28, 2004, p. 19)...

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

PS035984

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel